135 related articles for article (PubMed ID: 30628868)
1. Comparative Effectiveness of Metformin Dosage Uptitration Versus Adding Another Antihyperglycemic Medication on Glycemic Control in Type 2 Diabetes Patients Failing Initial Metformin Monotherapy: A Retrospective Cohort Study.
Mahabaleshwarkar R; Liu TL; Mulder H
Popul Health Manag; 2019 Oct; 22(5):457-463. PubMed ID: 30628868
[TBL] [Abstract][Full Text] [Related]
2. Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin Monotherapy.
Mahabaleshwarkar R; Templin M; Gohs F; Mulder H; DeSantis A; Ejzykowicz F; Rajpathak S; Wilkins N
Diabetes Educ; 2017 Oct; 43(5):495-505. PubMed ID: 28828933
[TBL] [Abstract][Full Text] [Related]
3. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
[TBL] [Abstract][Full Text] [Related]
4. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
5. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
6. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.
Hermans MP; Delibasi T; Farmer I; Lohm L; Maheux P; Piatti P; Malvolti E; Jörgens S; Charbonnel B
Curr Med Res Opin; 2012 Oct; 28(10):1635-45. PubMed ID: 23020253
[TBL] [Abstract][Full Text] [Related]
7. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes.
Desai U; Kirson NY; Kim J; Khunti K; King S; Trieschman E; Hellstern M; Hunt PR; Mukherjee J
Diabetes Care; 2018 Oct; 41(10):2096-2104. PubMed ID: 30131396
[TBL] [Abstract][Full Text] [Related]
8. Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study.
Yu S; Schwab P; Bian B; Radican L; Tunceli K
J Manag Care Spec Pharm; 2016 Mar; 22(3):272-80. PubMed ID: 27003557
[TBL] [Abstract][Full Text] [Related]
9. Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control.
Fu AZ; Sheehan JJ
Curr Med Res Opin; 2017 May; 33(5):853-858. PubMed ID: 28166431
[TBL] [Abstract][Full Text] [Related]
10. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
11. Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System.
Pantalone KM; Wells BJ; Chagin KM; Ejzykowicz F; Yu C; Milinovich A; Bauman JM; Kattan MW; Rajpathak S; Zimmerman RS
Diabetes Care; 2016 Sep; 39(9):1527-34. PubMed ID: 27519447
[TBL] [Abstract][Full Text] [Related]
12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
13. Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database.
Watson L; Das R; Farquhar R; Langerman H; Barnett AH
Curr Med Res Opin; 2016 Sep; 32(9):1465-75. PubMed ID: 26907851
[TBL] [Abstract][Full Text] [Related]
14. Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review.
Barnes NS; White PC; Hutchison MR
Pediatr Diabetes; 2012 Nov; 13(7):578-82. PubMed ID: 22646303
[TBL] [Abstract][Full Text] [Related]
15. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.
Rascati K; Richards K; Lopez D; Cheng LI; Wilson J
Diabetes Obes Metab; 2013 Oct; 15(10):901-5. PubMed ID: 23531154
[TBL] [Abstract][Full Text] [Related]
16. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control in youth-onset type 2 diabetes correlates with weight loss.
Chang N; Yeh MY; Raymond JK; Geffner ME; Ryoo JH; Chao LC
Pediatr Diabetes; 2020 Nov; 21(7):1116-1125. PubMed ID: 33103329
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records.
Arnold RJG; Yang S; Gold EJ; Farahbakhshian S; Sheehan JJ
PLoS One; 2018; 13(6):e0199011. PubMed ID: 29894495
[TBL] [Abstract][Full Text] [Related]
20. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
